NCT01416025View on ClinicalTrials.gov

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Fungal Infection
Interventions
DRUG

Prospective TDM Arm

Voriconazole dose will be adjusted based on per protocol obtained TDM levels

Trial Locations (1)

21205

Johns Hopkins, Baltimore

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT01416025 - A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing | Biotech Hunter | Biotech Hunter